| RIG-I-mediated activation of p38 MAPK is essential for viral induction of interferon and activation of dendritic cells SS Mikkelsen, SB Jensen, S Chiliveru, J Melchjorsen, I Julkunen, ... Journal of Biological Chemistry 284 (16), 10774-10782, 2009 | 135 | 2009 |
| Inflammatory cytokines break down intrinsic immunological tolerance of human primary keratinocytes to cytosolic DNA S Chiliveru, SH Rahbek, SK Jensen, SE Jørgensen, SK Nissen, ... The Journal of Immunology 192 (5), 2395-2404, 2014 | 66 | 2014 |
| A Retrospective Analysis Comparing APCEDEN® Dendritic Cell Immunotherapy with Best Supportive Care in Refractory Cancer C Kumar, S Kohli, S Chiliveru, PP Bapsy, M Jain, VS Suresh Attili, ... Immunotherapy 9 (11), 889-897, 2017 | 22 | 2017 |
| Induction of interferon-stimulated genes by Chlamydia pneumoniae in fibroblasts is mediated by intracellular nucleotide-sensing receptors S Chiliveru, S Birkelund, SR Paludan PLoS One 5 (4), e10005, 2010 | 14 | 2010 |
| On Brucella pathogenesis: looking for the unified challenge in systems and synthetic biology S Chiliveru, M Appari, P Suravajhala Systems and synthetic biology 9, 73-75, 2015 | 9 | 2015 |
| Substantial remission of prostate adenocarcinoma with dendritic cell therapy APCEDEN® in combination with chemotherapy C Kumar, J Bagga, S Chiliveru, S Kohli, A Bharadwaj, M Jain, S Inamdar, ... Future science OA 5 (10), FSO435, 2019 | 7 | 2019 |
| Substantial tumor regression in prostate cancer patient with extensive skeletal metastases upon Immunotherapy (APCEDEN): A case report B Sharan, S Chiliveru, J Bagga, S Kohli, A Bharadwaj, AK Vaid, C Kumar Medicine 99 (8), e18889, 2020 | 5 | 2020 |
| Complete remission of rare adenocarcinoma of the oropharynx with APCEDEN®(dendritic cell‐based vaccine): a case report C Kumar, S Kohli, S Chiliveru, M Jain, B Sharan Clinical Case Reports 5 (10), 1692, 2017 | 3 | 2017 |
| Molecular disparities in colorectal cancers of White Americans, Alabama African Americans, and Oklahoma American Indians HY Yamada, C Xu, KL Jones, PH O’Neill, M Venkateshwar, S Chiliveru, ... NPJ Precision Oncology 7 (1), 79, 2023 | 2 | 2023 |
| Effect of estrogen receptor modulator bazedoxifene on progression of carcinogen induced bladder cancer in female F344 rats V Madka, G Pathuri, SP Singh, S Chiliveru, A Singh, A Bao, N Stratton, ... Cancer Research 84 (6_Supplement), 7302-7302, 2024 | | 2024 |
| Targeting IL-23 for the interception of obesity-associated colorectal cancer V Madka, S Chiliveru, J Panneerselvam, G Pathuri, Y Zhang, N Stratton, ... Neoplasia 45, 100939, 2023 | | 2023 |
| Abstract LB114: Colon cancer preventive efficacy of ONC201 and naproxen alone or in combination in FAP relevant PIRC rat model V Madka, G Pathuri, K Venkatachalam, S Chiliveru, Y Zhang, N Kumar, ... Cancer Research 83 (8_Supplement), LB114-LB114, 2023 | | 2023 |
| Abstract A011: Effect of IL-23 knockdown on obesity driven CRC in high-fat diet fed Apcmin/+ mice V Madka, S Chiliveru, Y Zhang, N Stratton, A Bao, N Kumar, CV Rao Cancer Prevention Research 15 (12_Supplement_2), A011-A011, 2022 | | 2022 |
| IL-23 knockdown profoundly suppresses intestinal tumorigenesis in APCmin mice V Madka, S Chiliveru, G Pathuri, J Panneerselvam, R Rai, NC Stratton, ... Cancer Research 82 (12_Supplement), 3181-3181, 2022 | | 2022 |
| Activation and Regulation of DNA-driven Immune Responses in Keratinocytes: PhD Dissertation S Chiliveru Aarhus University, Department of Biomedicine, 2014 | | 2014 |
| Type III Interferons in Antiviral Immunity S Chiliveru, SR Paludan Viruses and Interferon: Current Research, 31, 2011 | | 2011 |
